Hepatic allograft rejection: Regulation of the immunogenicity of human intrahepatic biliary epithelial cells

Liver Transplantation and Surgery

Volumn 2, Issue 1, 1996, Pages 37-45

  Leon, M P ^a   Bassendine, M F ^a   Gibbs, P ^a   Burt, A D ^a   Thick, M ^a   Kirby, J A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HISTOCOMPATIBILITY ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ALLOGRAFT; ARTICLE; BILE DUCT; CELL CULTURE; EPITHELIUM CELL; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER TRANSPLANTATION; PHENOTYPE; PRIORITY JOURNAL;

EID: 0030066269     PISSN: 10743022     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.500020107     Document Type: Article

References (34)

1. 1 Vierling JM. Immune disorders of the liver and bile duct. Gastroenterol Clin North Am 1992 ; 21: 427–449.
2. 2 Hirschberg H, Evensus SA, Hennksen T, Thorsby E. The human mixed lymphocyte endothelium culture interaction. Transplantation 1975 ; 19: 495–504.
3. 3 Savage COS, Hughes CCW, McIntyre BW, Picard JK, Pober JS. Human CD4+ve T cells proliferate to HLADR+ve allogeneic vascular endothelium. Transplantation 1993 ; 56: 128–134.
4. 4 Augustin M, Dietrich A, Niedmer R, Kapp A, Schopf E, Ledbetter J, et al. Phorbol‐12‐myristate‐13‐acetatetreated human keratinocytes express B7‐like molecules that serve a costimulatory role in T cell activation. J Invest Dermatol 1993 ; 100: 275–281.
5. 5 Littman DR. Role of cell‐to‐cell interactions in T lymphocyte development and activation. Curr Opin Cell Biol 1989 ; 1: 920–928.
6. 6 Karjalainenk K. High sensitivity, low affinity—paradox of T‐cell receptor recognition. Curr Opin Immunol 1994 ; 6: 9–12.
7. 7 Hynes RO. Integrins: versatility, modulation, and signalling in cell adhesion. Cell 1992 ; 69: 11–25.
8. 8 Damle NK, Klussman K, Linsley PS, Aruffo A. Differential costimulatory effects of adhesion molecules B7, ICAM‐1, LFA‐3, and VCAM‐1 on resting and antigenprimed CD4+ T lymphocytes. J Immunol 1992 ; 148: 1985–1992.
9. 9 Krams SM, Ascher NL, Martinez OM. New immunologic insights into mechanisms of allograft rejection. Gastroenterol Clin North Am 1993 ; 22: 381–400.
10. 10 Saidman SL, Duquesnoy RJ, Zeevi A, Fung JJ, Starzl TE, Demetris AJ. Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes. Hepatology 1991 ; 13: 239–246.
11. 11 Duquesnoy RJ, Trager JD, Zeevi A. Propagation and characterization of lymphocytes from transplant biopsies. Crit Rev Immunol 1991 ; 10: 455–480.
12. 12 Volpes R, Van Den Oord JJ, Desmet VJ. Vascular adhesion molecules in acute and chronic liver inflammation. Hepatology 1992 ; 15: 269–275.
13. 13 Steinhoff G, Behrend M, Schrader B, Pichlmayr R. Intercellular immune adhesion molecules in human liver transplants: Overview on expression patterns of leukocyte receptor and ligand molecules. Hepatology 1993 ; 18: 440–453.
14. 14 Steinhoff G, Wonigeit K, Pichlmayr R. Analysis of sequential changes in major histocompatibility complex expression in human liver grafts after transplantation. Transplantation 1988 ; 45: 394–401.
15. 15 Adams DH, Hubscher SG, Shaw J, Johnson GD, Babbs C, Rothlein R, et al. Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 1991 ; 14: 426–431.
16. 16 Ballardini G, Mirakian R, Bianchi FB, Pisi E, Doniach D, Bottazzo GF. Aberrant expression of HLA‐DR antigens on bile duct epithelium in primary biliary cirrhosis: Relevance to pathogenesis. Lancet 1984 ; 2: 1009–1013.
17. 17 Auth MKH, Keitzer RA, Scholz M, Blaheta RA, Hottenrott EC, Herrmann G, et al. Establishment and immunological characterization of cultured human gallbladder epithelial cells. Hepatology 1993 ; 18: 546–555.
18. 18 Ayres RC, Neuberger JM, Shaw J, Joplin R, Adams DH. Intercellular adhesion molecule‐1 and MHC antigens on human intrahepatic bile duct cells: Effect of proinflammatory cytokines. Gut 1993 ; 34: 1245–1249.
19. 19 Joplin R, Strain AJ, Neuberger JM. Biliary epithelial cells from the liver of patients with primary biliary cirrhosis: Isolation, characterization, and short‐term culture. J Pathol 1990 ; 162: 255–260.
20. 20 Momburg F, Moldenhauer G, Hammerling GJ, Moller P. Immunohistochemical study of the expression of a Mr 34,000 human epithelium‐specific surface glycoprotein in normal and malignant tissues. Cancer Res 1987 ; 47: 2883–2891.
21. 21 Van Eyken P, Desmet VJ. Cytokeratins and the liver [Review]. Liver 1993 ; 13: 113–122.
22. 22 Rigg KM, Shenton BK, Murray IA, Givan AL, Taylor RMR, Lennard TWJ. A flow cytometric method technique for simultaneous analysis of human mononuclear cell‐surface antigens and DNA. J Immunol Methods 1989 ; 123: 177–184.
23. 23 Yeh CG, Hsi B, Faulk WP. Propidium iodide as a nuclear marker in immunofluorescence. II. Use with cellular identification and viability studies. J Immunol Methods 1981 ; 43: 269–275.
24. 24 Le Bouteiller PP, Mishal Z, Lemonnier FA, Kourilsky FM. Quantification by flow cytofluorimetry of HLA class I molecules at the surface of murine cells transformed by cloned HLA genes. J Immunol Methods 1983 ; 61: 301–315.
25. 25 Beltz BS, Burd GD, eds. Peroxidase techniques. In: Immunocytochemical Techniques: principles and practice. Oxford: Blackwell Scientific, 1989: 103–111.
26. 26 Kirby JA, Wilson JL. Allograft rejection: The role played by adhesion molecules. Transplant Rev 1994 ; 8: 114–126.
27. 27 Gill RG. T‐cell‐T‐cell collaboration in allograft responses. Curr Opin Immunol 1993 ; 5: 782–787.
28. 28 Guymer RH, Mandel TE. Immunosuppression using a monoclonal antibody to ICAM‐1 in murine allotransplantation. Transplant Proc 1992 ; 24: 218–219.
29. 29 Nakakura EK, McCabe SM, Zheng B, Shorthouse RA, Scheiner TM, Blank G, et al. Potent and effective prolongation by anti‐LFA‐1 monoclonal antibody monotherapy of non‐primarily vascularised heart allograft survival in mice without T cell depletion. Transplantation 1993 ; 55: 412–417.
30. 30 Talento A, Nguyen M, Blake T, Sirotina A, Fioravanti C, Burkholder D, et al. A single administration of LFA‐1 antibody confers prolonged allograft survival. Transplantation 1993 ; 55: 418–422.
31. 31 Fabre JW. Regulation of MHC expression. Immunol Lett 1991 ; 29: 3–8.
32. 32 Onishi S, Saibara T, Nakata S, Maeda T, Iwasaki S, Iwamura S, et al. Cytotoxic activity of spleen‐derived T lymphocytes against autologous biliary epithelial cells in autopsy patients with primary biliary cirrhosis. Liver 1993 ; 13: 188–192.
33. 33 Van Seventer GA, Shimizu Y, Horgan KJ, Shaw S. The LFA‐1 ligand ICAM‐1 provides an important costimulatory signal for T cell receptor‐mediated activation of resting T cells. J Immunol 1990 ; 144: 4579–4586.
34. 34 Paroli M, Carloni G, Franco A. Human hepatoma cell expressing MHC antigens display accessory cell function: Dependence on LFA‐1/ICAM‐1 interaction. Immunology 1994 ; 82: 215–221.